News
Impact Expansion Invests in neurocare
Impact Expansion invests in neurocare to expand mental health technologies, services, and international clinic footprint.
Impact Expansion has taken a minority stake in neurocare group AG, headquartered in Germany, a company specialised in mental healthcare. This funding will enable neurocare to further develop its technologies and services as well as expand its international footprint of mental health clinics.
Founded in 2015, neurocare’s best practice mental health platform empowers clinicians to provide personalised treatment for a range of psychological or neurological conditions. The platform integrates innovative mental healthcare methods and tools such as sleep hygiene, rTMS, QEEG and neurofeedback with existing approaches such as talk therapy and pharmaceuticals. These assets are all embedded within a cloud-based solution to drive productivity and improve outcomes.
Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing individualised therapy plans, scientifically proven to deliver superior clinical outcomes for Depression, ADHD, mental performance and other indications.
neurocare’s work directly contributes to Sustainable Development Goals #3 (Good Health and Well-Being) and #9 (Industry, Innovation and Infrastructure), striving to make everyday mental assistance accessible and affordable for vulnerable individuals.
Thomas Mechtersheimer, Founder and CEO of neurocare group, said: “This investment by another internationally renowned impact investor plus a follow-on investment from TVM is a strong endorsement of our progress and reinforces the confidence in our executive team and strategy. We will now drive the company’s growth and empower many more clinicians to support many more patients with our best practice platform.”
Erick Rinner and Ladislas de Guerre, Partner and Investment Manager at Impact Expansion, respectively, shared their enthusiasm for the collaboration: “We firmly believe that neurocare is uniquely positioned to lead the way in addressing the growing global mental health crisis. Their care infrastructure and innovative best-practice mental health platform represents a much-needed and timely advancement in the industry. We look forward to supporting Thomas and his management team to become a leading force within the mental healthcare sector.”
Tristan de Boysson, Managing Partner, TVM Capital Healthcare, added: "Our continued investment in neurocare is a clear reflection of our confidence in their vision and progress. We are excited to further support their efforts in delivering effective mental health solutions globally.”
This is the seventh investment for Impact Expansion Fund I, following investments in Potential Project (Skilling), SomniPlanet (Sleep apnea home healthcare provider), Mon Kit Solaire (DIY solar panels), BeliVert (Energy solutions), Helpper (Community sharing platform), and MoveUp (Orthopaedic implants).
About Impact Expansion
Impact Expansion is an investment manager sponsored by KOIS, a pioneer in impact investing, which currently manages over €500 million in impact-focused private equity. Impact Expansion operates from its offices in Brussels and Paris, with the mission to invest in businesses that align with three strategic themes:
• Skilling & Inclusion – investing in sectors like education, training, social inclusion, and youth employment to combat long-term unemployment and isolation.
• Climate & Nature – supporting companies that offer solutions to environmental challenges related to the climate crisis, pollution, and biodiversity loss, while promoting the circular economy.
• Health & Well-being – focusing on improving access to high-quality care.
Impact Expansion manages a €150m fund taking both minority and majority stakes, investing between €5 and €30 million in companies based in Western Europe. By leveraging deep expertise in impact investing alongside disciplined private equity practices, the team aims to achieve outstanding social and environmental outcomes while delivering top-tier financial returns.
About TVM Capital Healthcare
TVM Capital Healthcare is an emerging markets-focused healthcare private equity firm headquartered in Dubai and Singapore, with offices in Riyadh and Ho Chi Minh City. The firm invests expansion and growth capital in healthcare companies to improve local access to quality care.
Investment and operating partners as well as a strong group of senior advisors have long-standing international track records in healthcare investing, active board work, contributions to strategy development and implementation, and deep healthcare operations experience. The firm partners with local Middle Eastern and Southeast Asian management teams to build domestic or regional sector champions and selectively back companies from Europe or North America for expansion into the firm’s two key target geographies.
TVM Capital Healthcare’s investment and operating approach combines strong commercial value creation and returns with impact and responsible (ESG) investing.
About neurocare group AG
neurocare group AG has developed a best practice mental health platform, empowering clinicians to offer their patients, through personalised therapy, the best care for a variety of psychological or neurological conditions with more sustainable clinical outcomes.
These therapy plans integrate innovative methods and tools, such as psychotherapy, neuromodulation and sleep hygiene, as well as medication. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing personalised therapy plans that improve self-regulation, resilience and social skills, while being cost-effective for the healthcare system.
The key technology elements of neurocare’s platform are developed in-house, including leading TMS and EEG devices, a cloud-based software platform, as well as an online academy to give professionals the tools and neuroscientific understanding to properly apply these solutions in clinical practice.
neurocare’s mental health platform is currently applied throughout the company’s own clinics across the US, the UK, the Netherlands and Australia, as well as in a growing number of third-party clinics.
www.neurocaregroup.com
Contacts
Erick Rinner (Partner): erick@impact-expansion.com / +41 79 128 20 44
Ladislas de Guerre (Investment Manager): ladislas@impact-expansion.com / +33 6 69 91 08 20
Elvire Perrin (Investor Relations): elvire@impact-expansion.com / +32 480 62 73 23
Impact Expansion has taken a minority stake in neurocare group AG, headquartered in Germany, a company specialised in mental healthcare. This funding will enable neurocare to further develop its technologies and services as well as expand its international footprint of mental health clinics.
Founded in 2015, neurocare’s best practice mental health platform empowers clinicians to provide personalised treatment for a range of psychological or neurological conditions. The platform integrates innovative mental healthcare methods and tools such as sleep hygiene, rTMS, QEEG and neurofeedback with existing approaches such as talk therapy and pharmaceuticals. These assets are all embedded within a cloud-based solution to drive productivity and improve outcomes.
Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing individualised therapy plans, scientifically proven to deliver superior clinical outcomes for Depression, ADHD, mental performance and other indications.
neurocare’s work directly contributes to Sustainable Development Goals #3 (Good Health and Well-Being) and #9 (Industry, Innovation and Infrastructure), striving to make everyday mental assistance accessible and affordable for vulnerable individuals.
Thomas Mechtersheimer, Founder and CEO of neurocare group, said: “This investment by another internationally renowned impact investor plus a follow-on investment from TVM is a strong endorsement of our progress and reinforces the confidence in our executive team and strategy. We will now drive the company’s growth and empower many more clinicians to support many more patients with our best practice platform.”
Erick Rinner and Ladislas de Guerre, Partner and Investment Manager at Impact Expansion, respectively, shared their enthusiasm for the collaboration: “We firmly believe that neurocare is uniquely positioned to lead the way in addressing the growing global mental health crisis. Their care infrastructure and innovative best-practice mental health platform represents a much-needed and timely advancement in the industry. We look forward to supporting Thomas and his management team to become a leading force within the mental healthcare sector.”
Tristan de Boysson, Managing Partner, TVM Capital Healthcare, added: "Our continued investment in neurocare is a clear reflection of our confidence in their vision and progress. We are excited to further support their efforts in delivering effective mental health solutions globally.”
This is the seventh investment for Impact Expansion Fund I, following investments in Potential Project (Skilling), SomniPlanet (Sleep apnea home healthcare provider), Mon Kit Solaire (DIY solar panels), BeliVert (Energy solutions), Helpper (Community sharing platform), and MoveUp (Orthopaedic implants).
About Impact Expansion
Impact Expansion is an investment manager sponsored by KOIS, a pioneer in impact investing, which currently manages over €500 million in impact-focused private equity. Impact Expansion operates from its offices in Brussels and Paris, with the mission to invest in businesses that align with three strategic themes:
• Skilling & Inclusion – investing in sectors like education, training, social inclusion, and youth employment to combat long-term unemployment and isolation.
• Climate & Nature – supporting companies that offer solutions to environmental challenges related to the climate crisis, pollution, and biodiversity loss, while promoting the circular economy.
• Health & Well-being – focusing on improving access to high-quality care.
Impact Expansion manages a €150m fund taking both minority and majority stakes, investing between €5 and €30 million in companies based in Western Europe. By leveraging deep expertise in impact investing alongside disciplined private equity practices, the team aims to achieve outstanding social and environmental outcomes while delivering top-tier financial returns.
About TVM Capital Healthcare
TVM Capital Healthcare is an emerging markets-focused healthcare private equity firm headquartered in Dubai and Singapore, with offices in Riyadh and Ho Chi Minh City. The firm invests expansion and growth capital in healthcare companies to improve local access to quality care.
Investment and operating partners as well as a strong group of senior advisors have long-standing international track records in healthcare investing, active board work, contributions to strategy development and implementation, and deep healthcare operations experience. The firm partners with local Middle Eastern and Southeast Asian management teams to build domestic or regional sector champions and selectively back companies from Europe or North America for expansion into the firm’s two key target geographies.
TVM Capital Healthcare’s investment and operating approach combines strong commercial value creation and returns with impact and responsible (ESG) investing.
About neurocare group AG
neurocare group AG has developed a best practice mental health platform, empowering clinicians to offer their patients, through personalised therapy, the best care for a variety of psychological or neurological conditions with more sustainable clinical outcomes.
These therapy plans integrate innovative methods and tools, such as psychotherapy, neuromodulation and sleep hygiene, as well as medication. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing personalised therapy plans that improve self-regulation, resilience and social skills, while being cost-effective for the healthcare system.
The key technology elements of neurocare’s platform are developed in-house, including leading TMS and EEG devices, a cloud-based software platform, as well as an online academy to give professionals the tools and neuroscientific understanding to properly apply these solutions in clinical practice.
neurocare’s mental health platform is currently applied throughout the company’s own clinics across the US, the UK, the Netherlands and Australia, as well as in a growing number of third-party clinics.
www.neurocaregroup.com
Contacts
Erick Rinner (Partner): erick@impact-expansion.com / +41 79 128 20 44
Ladislas de Guerre (Investment Manager): ladislas@impact-expansion.com / +33 6 69 91 08 20
Elvire Perrin (Investor Relations): elvire@impact-expansion.com / +32 480 62 73 23
